How to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients

Sponsor
Becerra, Pablo (Other)
Overall Status
Terminated
CT.gov ID
NCT05193695
Collaborator
(none)
20
1
2
8.7
2.3

Study Details

Study Description

Brief Summary

Ankle fractures are one of the main causes of hospitalization due to injuries in Chile, which also have a discharge and partial load time of approximately 12 weeks in the recovery process. This generates disuse and atrophy of the posterior musculature of the leg called the triceps sural, which makes it difficult to restart and perform the gait. We conducted this research because practically all patients with this type of diagnosis have trigger points in these muscles, and dry needling technique is one of the best for its treatment, but has the disadvantage that it produces post dry needling pain of 48 hours and there is not enough information, or consensus on which method is better to reduce post dry needling pain. This study aims to prove wich technique is most useful in reducing pain post dry needling for the treatment of trigger points in the triceps sural muscle in ankle post fracture patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Treadmill exercise
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Heat or Excesice in Treadmill as Techique to Reduce Dry Needling Pain in Treatment of Trigger Points of Muscle Triceps Sural in Ankle Post Fracture Patients
Actual Study Start Date :
Aug 9, 2018
Actual Primary Completion Date :
Apr 4, 2019
Actual Study Completion Date :
Apr 30, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Patients remained in the supine position for 20 minutes lying on a stretcher after dry needling.

Experimental: Treadmill

The patients walked on a treadmill for 20 minutes after dry needling, with an inclination of 5 degrees and at a speed at which the perceived exertion was 5 according to the Borg CR10 scale (Chen et al., 2002).

Other: Treadmill exercise
the patients walked on a treadmill for 20 minutes after dry needling, with an inclination of 5 degrees and at a speed at which the perceived exertion was 5 according to the Borg CR10 scale (Chen et al., 2002)
Other Names:
  • Treadmill after dry needling
  • Outcome Measures

    Primary Outcome Measures

    1. Perceived pain intensity [Change from baseline (baseline and immediately after treatment)]

      Pain will be measured by the Visual Analog Scale for pain (VAS) from 0 to 10, where higher values represent a worse outcome.

    2. Ankle Range of Motion (ROM) [Change from baseline (baseline and immediately after treatment)]

      It is the degree of angular movement allowed by the ankle joint measured by kinovea.

    Secondary Outcome Measures

    1. Muscular strength of triceps sural [Change from baseline (baseline and immediately after treatment)]

      By means of the heel rise test, the patient must perform a bipodal plantiflexion measured in the maximum number of repetitions in 30 seconds.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Ages between 18 and 60 years of age.

    • Man or woman.

    • At least one trigger point, active or latent, in the triceps sural muscle of the fractured ankle.

    • Perform full load without using technical aids.

    Exclusion Criteria:
    • Use of analgesics.

    • Insurmountable fear of needles.

    • Immune disease.

    • Clotting disorders.

    • Sensory disorders.

    • Psychiatric / psychological illness.

    • Cancer.

    • Rheumatic diseases.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Complejo Hospitalario San Jose Santiago Chile 8380419

    Sponsors and Collaborators

    • Becerra, Pablo

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pablo Yañez Becerra, Physical therapist, Becerra, Pablo
    ClinicalTrials.gov Identifier:
    NCT05193695
    Other Study ID Numbers:
    • Becerra
    First Posted:
    Jan 18, 2022
    Last Update Posted:
    Jan 31, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Pablo Yañez Becerra, Physical therapist, Becerra, Pablo
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 31, 2022